Savient Secures Last-Minute Generic Oxandrin Ban
Drug maker Savient Pharmaceuticals Inc. was able to buy more time for its weight-gain treatment Oxandrin Tuesday when it persuaded a U.S. federal appeals court at the last minute to issue...To view the full article, register now.
Already a subscriber? Click here to view full article